Login / Register


Password: [Lost?]

New User? Click here for your FREE subscription

Long Term Care Professionals
Long Term Care Professionals Long Term Care Professionals

Follow Us

NEWS-Line on Twitter NEWS-Line on Facebook NEWS-Line on Google+ NEWS-Line on LinkedIn NEWS-Line on Pinterest

Long Term Care Conferences &
Educational Opportunities

June 1 - 02

The Excellence Conference 2019 Austin

Excellence in Advanced Practice

June 2 - 05



June 11 - 14

Skin, Bones, Hearts & Private Parts 2019 Destin CME/CE Conference

Skin, Bones, Hearts & Private Parts

June 12 - 15

NEXT Conference & Exposition

American Physical Therapy Association

June 18 - 23

2019 AANP National Conference

American Association of Nurse Practitioners

More Events

Blocking Toxic-Protein Production In ALS | NEWS-Line for Long Term Care Professionals

Blocking Toxic-Protein Production In ALS


Patients with ALS frequently have a string of repeated DNA code in the cells of their brain, carrying hundreds to thousands of copies within the gene C9orf72. New research looks at what triggers these repeated sequences to eventually produce the toxic proteins that are associated with ALS, frontotemporal dementia, and other neurodegenerative diseases in patients carrying the C9orf72 mutation, the most common cause of inherited ALS. The work finds that neuronal excitation and stress trigger the protein production in cells, and reveals that targeting this stress response with a known drug could reduce toxic protein production.

“Understanding what triggers toxic proteins production helped us hone in on drugs that could block them in laboratory tests,” said co-senior author Aaron Haeusler, PhD, Assistant Professor of Neuroscience within the Vickie & Jack Farber Institute for Neuroscience and the Weinberg ALS Center at Jefferson (Philadelphia University + Thomas Jefferson University). The research was published in EMBO Molecular Medicine.

Through a collaboration with co-lead investigator Davide Trotti, PhD, and co-author Piera Pasinelli, PhD, who leads the Jefferson Weinberg ALS Center, Dr. Haeusler and colleagues tested what causes the repeat DNA sequences within C9orf72 to activate and produce toxic protein. Suspecting stressors as a possible trigger, the investigators tested a number of agents that cause neurons to turn on the stress responses. Indeed, many of these also initiated production of toxic protein. The researchers also showed that neuronal over-excitation, similar to what happens during a seizure, also triggered the protein production.

“Both cellular stress and over-excitation eventually converge into the integrated stress response,” said first author Thomas Westergard, a graduate student in Dr. Trotti’s lab.

Once the integrated stress response is activated, it’s difficult to stop the production of these toxic proteins. But honing in on this over-arching cellular mechanism offered the researchers a glimpse into specific methods that might block the neuron-damaging response.

The drug trazodone, which is approved for the treatment of depression, is known to act on parts of the integrated stress response. So, the researchers tested the drug in their models of disease, and found that it could indeed block production of toxic protein in a cellular model that contained the repeat mutations.

“This is a significant step forward in our collaborative approach,” said Dr. Pasinelli.“Working together allowed us to speed up the research process getting from the identification of the “pathogenic stress” to testing a potentially useful drug. ALS is a complex and heterogenous disease that needs this collaborative approach, with each lab contributing its own expertise, to fill the gaps and to put together this complex puzzle in a systematic and efficient way,”

The researchers are now expanding their research to screen for other molecules that might work better than the drug trazodone.

The work was supported NIH (R21-NS090912) (4R00NS091486-03), Muscular Dystrophy Association, the Robert Packard Center for ALS Research, and Farber Family Foundation grants supported this work. The authors report no conflicts of interest.

Article Reference: Thomas Westergard, Kevin McAvoy, Katelyn Russell, Xinmei Wen, Yu Pang, Brandie Morris, Piera Pasinelli, Davide Trotti, Aaron Haeusler, “Repeat‐associated non‐AUG translation in C9orf72‐ALS/FTD is driven by neuronal excitation and stress,” EMBO Molecular Medicine, DOI: 10.15252/emmm.201809423, 2019.

[photo credit: pixbay]

Share This!

Long Term Care Jobs

Med Tech

The Blood Center

Director of Nursing

Iowa County Bloomfield Healthcare and Rehabilitation Center
Dodgeville, Wisconsin

Physical Therapist

Memorial Medical Center
New Mexico

Nurse Practitioner

Oak Valley Hospital
Oakdale, California

Orthopedic Physician Assistant

EmergeOrtho | Blue Ridge Division
Asheville area, North Carolina

Speech Therapy

Brefeld Physical Therapy
Belleville, Illinois

More Jobs
(Dismiss) Thank you for visiting NEWS-Line! Please sign up, login, or follow us on your favorite social networks
to receive custom tailored eNews, job listings, and educational opportunities for your specific profession.